These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5316970)

  • 1. [SWAN mice. (Swiss antinuclear). Animal models for the study of acute, disseminated lupus erythematosus and amyloidosis. Immunopathological study].
    Monier JC; Thivolet J; Beyvin AJ; Czyba JC; Schmitt D; Salussola D
    Pathol Eur; 1971; 6(4):357-83. PubMed ID: 5316970
    [No Abstract]   [Full Text] [Related]  

  • 2. [A chronological study of thymic crystalline inclusions and autoimmune disorders in Swan and NZB mice (author's transl)].
    Schmitt D; Monier JC; Viac J; Thivolet J
    Ann Immunol (Paris); 1975; 126C(4):399-410. PubMed ID: 174485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-immunity and systemic lupus erythematosus.
    Whaley K
    Med Lab Technol; 1972 Apr; 29(2):133-42. PubMed ID: 4116076
    [No Abstract]   [Full Text] [Related]  

  • 4. Palmerston North mice, a new animal model of systemic lupus erythematosus.
    Walker SE; Gray RH; Fulton M; Wigley RD; Schnitzer B
    J Lab Clin Med; 1978 Dec; 92(6):932-45. PubMed ID: 310856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H; Weill B; Fournier C; Batteux F
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible relation between low thymosine-like activity in the serum of Swan mice (Swiss antinuclear) and the formation of crystals in their thymic epithelial.
    Schmitt DM; Monier JC
    Experientia; 1974 Nov; 30(11):1349-51. PubMed ID: 4548025
    [No Abstract]   [Full Text] [Related]  

  • 7. Diseases of autoimmunity.
    Dixon FJ
    Natl Cancer Inst Monogr; 1982; 60():181-92. PubMed ID: 6214718
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lupus erythematosus--a model of an autoimmune disease].
    Sönnichsen N
    Dermatol Monatsschr; 1985; 171(8):481-92. PubMed ID: 3899754
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pathogenic significance of "autoantibodies" in NZB-W-F1 hybrids. 3. Immunohistological studies].
    Barthelmes H; Haustein UF; Sönnichsen N
    Acta Biol Med Ger; 1973; 30(2):275-86. PubMed ID: 4579376
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune mechanisms in systemic lupus erythematosus.
    Butler WT; Rich RR
    Perspect Nephrol Hypertens; 1976; 3():3-11. PubMed ID: 129760
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental models of systemic lupus erythematosus: anti-dsDNA in murine lupus.
    Blank M; Shoenfeld Y
    Rheumatology (Oxford); 2005 Sep; 44(9):1086-9. PubMed ID: 15914499
    [No Abstract]   [Full Text] [Related]  

  • 12. Fate of human IgG from lupus erythematosus antinuclear antibody positive sera passively transfered to mice.
    Herrera-Esparza R; Guzman-Enriquez L; Avalos-Diaz E
    Rev Rhum Engl Ed; 1996 Feb; 63(2):111-8. PubMed ID: 8689281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Letter: Antinuclear autoimmunization in Swan mice. Prevention and regression by treatment with thymosin].
    Monier JC; Deschaux P; Fontanges R
    Nouv Presse Med; 1975 Feb; 4(7):507. PubMed ID: 1079341
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus.
    Goust JM
    Immunol Ser; 1990; 50():449-63. PubMed ID: 2151125
    [No Abstract]   [Full Text] [Related]  

  • 15. Aleutian mink and New Zealand mice: models of viral induced connective tissue disease.
    Norton WL
    Rheumatology; 1970; 3():194-223. PubMed ID: 4110380
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of autoimmune phenomena during the development of casein-induced amyloidosis in C3H and NZB-BL mice.
    Hardt F; Wanstrup J; Elling P; Ranlov P
    Acta Pathol Microbiol Scand Suppl; 1972; 233():178-82. PubMed ID: 4538553
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic lupus erythematosus--recent clues from congenic strains.
    Henry T; Mohan C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):207-12. PubMed ID: 15995581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological analysis of 16 antinuclear antibodies in disseminated lupus erythematosus].
    Boulila Elgaied A; Hintati B; Fakhfakh F; Karray H; Hachicha J; Jarraya A; Ayadi H
    Tunis Med; 1993 Feb; 71(2):91-5. PubMed ID: 8322428
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoantibodies in systemic lupus erythematosus of late onset.
    Wysenbeek AJ; Mandel DR; Mayes MD; Clough JD
    Cleve Clin Q; 1985; 52(2):119-22. PubMed ID: 3875440
    [No Abstract]   [Full Text] [Related]  

  • 20. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.